Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial.
The Lancet. Infectious diseases（2023）
摘要
The Netherlands Organization for Health Research and Development and the Dutch Kidney Foundation.
更多查看译文
关键词
mrna vaccines,kidney transplant recipients,immunogenicity
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要